T1	Participants 427 632	Sixty-one patients with ovarian cancer or endometrial cancer who underwent retroperitoneal lymph node resection were assigned at random to a retroperitoneal partial "no-closure" group or a "closure" group.
T2	Participants 738 791	Lymphocysts appeared in 23/61 patients (38%) in total
